MedTrace Logo

Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern

NCT01251302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 171

Last updated 2019-01-31

No results posted yet for this study

Summary

To investigate whether the use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood assay changes the diagnostic testing pattern in patients referred to a cardiologist for the evaluation of chest pain or anginal equivalent symptoms.

Conditions

Interventions

DIAGNOSTIC_TEST

Corus CAD (ASGES)

Age/Sex/Gene Expression Score - ASGES

Sponsors & Collaborators

  • CardioDx

    lead INDUSTRY

Principal Investigators

  • Michael Zapien, MS · CardioDx, Inc.

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-02-29
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01251302 on ClinicalTrials.gov